Current Shareholder Structure (August 13, 2024)
– according to our information –
| PNO Asset Management GmbH*¹ | 25.74% |
| Youshi Medical (Suzhou) Co. Ltd., China*² | 12.40% |
| Merval AG, Switzerland*³ | 9.69% |
| Axxion S.A., Luxemburg | 8.16% |
| Noes Beheer B.V., Netherlands*⁴ | 7.48% |
| Ratio Capital Management B.V., Netherlands | 6.80% |
| Deepblue Holding AG, Switzerland*⁵ | 3.60% |
| Sum | |
| Free-Float*⁶ | |
| Sum Total | 100% |
| of that Organs (board of directors and supervisory board): | 4.30% |
*1 controlled by Dr. G. Haindl
*2 controlled by Feipeng Huang
*3 controlled by Jürgen W. Krebs
*4 controlled by Jan Albert de Vries
*5 controlled by Rubino Di Girolamo
*6 according to Deutsche Börse